The rapid proliferation of tumor cells enhances glucose uptake through the overexpression of the glucose transporters, GLUT1 and GLUT3, to relieve glucose dependence, resulting in glucose deficiency in the TME. The gene discussed is SLC2A3; the disease is neoplasm.